Is Cortexin FDA approved?

Cortexin is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

P21 is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

How is Cortexin administered in research settings?

In research settings, Cortexin is typically administered via the intramuscular route. PeptideBase does not provide dosing or administration instructions.

How is P21 administered in research settings?

In research settings, P21 is typically administered via the subcutaneous or intranasal routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Cortexin vs P21

Peptide Comparison

Cortexin vs P21

Q: What is the difference between Cortexin and P21?

Cortexin: Polypeptide bioregulator from bovine cortex; modulates neurotransmitter activity; activates GABA and dopamine systems; reduces excitotoxicity; stimulates neuronal repair P21: Derived from CNTF; increases BDNF expression and promotes hippocampal neurogenesis; modulates PI3K/Akt pathway

Both are Neuro & Cognitive peptides.

Cortexin

Cortexin-10

CognitiveNot EvaluatedResearch Only

Half-life: Unknown

4 providers listed

Full Cortexin profile →

P21

CNTF fragment

CognitiveNot EvaluatedResearch Only

Half-life: Unknown

4 providers listed

Full P21 profile →

Bottom line

Cortexin carries stronger published evidence (RCT, 2 key studies) than P21 (Animal, 2); both are research compounds.

Quick Verdict

Cortexin

Evidence

Emerging Clinical

P21

Evidence

Preclinical

Which One Should You Choose?

Your goal	Better option
Stronger clinical evidence	Cortexin

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Cortexin

P21

Mechanism Family

Neuro & Cognitive

Half-life

Unknown

FDA Status

not evaluated

Admin Routes

intramuscular

subcutaneous, intranasal

Availability

Research Only

Providers

4 listed

Avail. Notes

Russian polypeptide preparation from cattle cerebral cortex. Registered in Russia for neurological conditions. No FDA approval, no NDA or IND, not on any FDA list. Research chemical in US.

CNTF-derived pentapeptide fragment studied for cognitive enhancement in animal models. No FDA approval, no NDA or IND. Not on any FDA list. Very limited human research. Research compound.

Research Evidence

Cortexin

Emerging ClinicalRCT · 2 key studies · most recent 2019

P21

PreclinicalAnimal · 2 key studies · most recent 2017

Research Citations

Cortexin

RCT2019 · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Evaluation of the efficacy and safety of cortexin in the complex rehabilitation of verticalization in patient…

Review2013 · Advances in gerontology

Neuroprotective effects of peptides bioregulators in people of various age

P21

Animal2017 · Journal of Alzheimer's Disease

Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Tre…

Animal2010 · FEBS Letters

Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic…

About Cortexin

Polypeptide bioregulator from bovine cortex; modulates neurotransmitter activity; activates GABA and dopamine systems; reduces excitotoxicity; stimulates neuronal repair

Research Areas

neuroprotection and neuronal survival supportcognitive function improvement — documented in Russian clinical settingsantioxidant activity in CNS tissueEEG normalization and neurotrophic factor expression

About P21

Derived from CNTF; increases BDNF expression and promotes hippocampal neurogenesis; modulates PI3K/Akt pathway

Research Areas

neurogenesisBDNF upregulationmemory enhancementneuroprotection

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Cortexin

Reported (Unverified — Pending Clinical Review)

bovine protein allergy

No established clinical contraindications

P21

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Find Providers

Where to source these peptides

Providers offering

Cortexin

4 listed

Browse directory →

Providers offering

P21

4 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Neuro & Cognitive Comparisons

Browse all peptides →

Educational research tools — not medical advice.